7147-52-6 Usage
General Description
N-(5-Bromobiphenyl-2-yl)acetamide, also known as 2-Acetylamino-5-bromobiphenyl, is a chemical compound with the molecular formula C16H13BrNO. It is a derivative of biphenyl, containing a bromine atom and an acetamide functional group. N-(5-Bromobiphenyl-2-yl)acetamide is commonly used in organic synthesis and pharmaceutical research as a building block for the synthesis of various biologically active molecules and pharmaceutical agents. It is also utilized as a reagent in chemical reactions and as a precursor in the manufacturing of novel organic compounds. N-(5-Bromobiphenyl-2-yl)acetamide exhibits potential pharmacological properties and has been studied for its potential therapeutic applications. Its structure and properties make it a valuable tool in various chemical and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 7147-52-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,4 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 7147-52:
(6*7)+(5*1)+(4*4)+(3*7)+(2*5)+(1*2)=96
96 % 10 = 6
So 7147-52-6 is a valid CAS Registry Number.
InChI:InChI=1/C14H12BrNO/c1-10(17)16-14-8-7-12(15)9-13(14)11-5-3-2-4-6-11/h2-9H,1H3,(H,16,17)
7147-52-6Relevant articles and documents
Ruthenium(II)-catalyzed C-H arylation of anilides with boronic acids, borinic acids and potassium trifluoroborates
Hubrich, Jonathan,Himmler, Thomas,Rodefeld, Lars,Ackermann, Lutz
supporting information, p. 474 - 480 (2015/03/05)
An in situ generated cationic ruthen-ium(II) catalyst allowed for robust C-H arylations of anilides with boronic acids. The optimized ruthenium catalyst was found to be both site selective and chemoselective, thereby providing the monoarylated products in
QUATERNARY AMMONIUM SALT COMPOUNDS
-
, (2012/03/10)
[Problem] The object of the present invention is to provide a novel compound having 132 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. [Means for Solving the Problem] The present invention is a quaternary ammonium salt compounds represented by formula (I), or a pharmaceutically acceptable salt thereof, with superior β32 adrenergic receptor agonist activity and muscarinic receptor antagonist activity.